These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 4193269)

  • 21. Treatment with xylometazoline (Otrivin) nosedrops over a six-week period.
    Petruson B
    Rhinology; 1981 Sep; 19(3):167-72. PubMed ID: 6171024
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [The action of an oral rhinological agent on the nasal mucous membrane (author's transl)].
    Schumann K
    MMW Munch Med Wochenschr; 1974 May; 116(21):1089-92. PubMed ID: 4135042
    [No Abstract]   [Full Text] [Related]  

  • 23. [On the effect of mucosa-shrinking nose drops].
    Osterwald L
    HNO; 1966 Feb; 14(2):39-41. PubMed ID: 4168347
    [No Abstract]   [Full Text] [Related]  

  • 24. [The treatment of rhinitis with the Dexa-Rhinospray dosage regulated aerosol and its results].
    Lindemann R
    Landarzt; 1966 Feb; 42(4):168-9. PubMed ID: 4167299
    [No Abstract]   [Full Text] [Related]  

  • 25. A topical nasal decongestant for children.
    Neffson AH
    Eye Ear Nose Throat Mon; 1968 Mar; 47(3):121-3. PubMed ID: 4171734
    [No Abstract]   [Full Text] [Related]  

  • 26. Long-term use of oxy- and xylometazoline nasal sprays induces rebound swelling, tolerance, and nasal hyperreactivity.
    Graf P
    Rhinology; 1996 Mar; 34(1):9-13. PubMed ID: 8739860
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Exploratory study of the decongestive effect of Rhinopront syrup in adults and in children with acute rhinitis.
    Lebacq E; Gline JP; Joue P; Stockis A; Calderon P; Van Schoor O; Deroubaix X; Schwegler F
    Clin Trials Metaanal; 1994 Oct; 29(2-3):113-24. PubMed ID: 10151073
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Clinical test of oxymetazoline-HCl-nose drops for infants (Nasivin 0,01 per cent)].
    Rüggeberg F
    Z Allgemeinmed; 1974 Apr; 50(11):535-7. PubMed ID: 4135074
    [No Abstract]   [Full Text] [Related]  

  • 29. Nasal airway resistance after decongestion with a nasal spray or a bellows device.
    Jessen M; Ivarsson A; Malm L
    Rhinology; 1996 Mar; 34(1):28-31. PubMed ID: 8739865
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Nasal decongestants and eye drops: keep out of children's reach!].
    Poulin-Chartrand S
    Perspect Infirm; 2013; 10(2):63. PubMed ID: 23539872
    [No Abstract]   [Full Text] [Related]  

  • 31. An in vitro technique for testing nasal vasodilating agents.
    Jackson RT
    Otolaryngol Head Neck Surg; 1980; 88(4):434-8. PubMed ID: 6085151
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A comparative preference study between xylometazoline nasal dose spray (Otrivin) and oxymetazoline single-dose pipettes (Nezeril).
    Ekedahl C; Geterud A; Petruson B; Aust R; Odkvist L
    Rhinology; 1983 Sep; 21(3):287-8. PubMed ID: 6195722
    [No Abstract]   [Full Text] [Related]  

  • 33. [Rhinitis medicamentosa in cytological assessment of the nasal mucosa].
    Tarchalska B; Gotlib T; Samoliński B
    Pol Merkur Lekarski; 2005 Sep; 19(111):288-90. PubMed ID: 16358845
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sustained use of xylometazoline nasal spray shortens the decongestive response and induces rebound swelling.
    Graf P; Juto JE
    Rhinology; 1995 Mar; 33(1):14-7. PubMed ID: 7540314
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [A clincial useful method for measuring nasal patency (author's transl)].
    Barree GO; Feenstra L
    Laryngol Rhinol Otol (Stuttg); 1974 Mar; 53(5):357-63. PubMed ID: 4136281
    [No Abstract]   [Full Text] [Related]  

  • 36. Changes in the patency of the upper nasal passage induced by histamine and antihistamines.
    Bentley AJ; Jackson RT
    Laryngoscope; 1970 Dec; 80(12):1859-70. PubMed ID: 4099288
    [No Abstract]   [Full Text] [Related]  

  • 37. [Clinical evaluation of the preparation "Betadrin-Polfa"].
    Klonowski S; Semczuk B; Pomykalski M; Czerwonka R
    Pol Tyg Lek; 1969 Feb; 24(6):209-11. PubMed ID: 4180773
    [No Abstract]   [Full Text] [Related]  

  • 38. Plasma exudation in rhinitis.
    Eccles R
    Clin Exp Allergy; 1992 Mar; 22(3):319-20. PubMed ID: 1375125
    [No Abstract]   [Full Text] [Related]  

  • 39. Temperature changes following systemic and intracerebral administration of naphazoline and B-45 to the rat.
    Lomax P
    Proc West Pharmacol Soc; 1967; 10():67-9. PubMed ID: 4168060
    [No Abstract]   [Full Text] [Related]  

  • 40. [Evaluation of the effects of nasal decongestants with acoustic rhinometry].
    Tanaka T; Okita W; Kase Y; Iinuma T
    Nihon Jibiinkoka Gakkai Kaiho; 1994 Feb; 97(2):207-12. PubMed ID: 7513351
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.